Zions Bancorporation, N.A. Galapagos Nv Transaction History

Zions Bancorporation, N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$52.17 - $70.2 $4,903 - $6,598	-94 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$68.86 - $83.34 $344 - $416	-5 Reduced 5.05%	94 $6,000
Q1 2021 May 13, 2021	BUY	$76.15 - $111.94 $2,360 - $3,470	31 Added 45.59%	99 $8,000
Q4 2020 Feb 12, 2021	BUY	$96.85 - $148.25 $387 - $593	4 Added 6.25%	68 $7,000
Q3 2020 Nov 13, 2020	BUY	$122.47 - $213.56 $7,470 - $13,027	61 Added 2033.33%	64 $9,000
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $429 - $822	3 New	3 $0

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.69B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.